Prescription Drug Affordability Board (PDAB)

PDAB is accepting policy recommendations for consideration through October 6

The Prescription Drug Affordability Board (PDAB) is accepting potential policy recommendations to submit in its 2023 recommendations to the Oregon Legislature. PDAB is charged with making recommendations that are solution based that will make prescription drugs more affordable for Oregonians.

Submissions will be accepted for board consideration until 5 pm on October 6 at PDAB@dcbs.oregon.gov. Board members will review and evaluate submissions for consideration at the November board meeting.

PDAB seeks a clinician to serve on the board

The Prescription Drug Affordability Board is seeking applicants with a background in clinical medicine to fill a vacancy. We strongly encourage clinicians from rural Oregon to apply. Submit applications in Workday by 5 p.m. Monday October 30, 2023. Learn more in this information letter.

Next PDAB meeting: October 18, 2023
9:30 AM Pacific Time

About the PDAB

Senate Bill 844 created the Prescription Drug Affordability Board (PDAB) to evaluate the cost of prescription drugs and determine whether they present an affordability challenge for consumers and health systems in Oregon. PDAB’s review will inform rulemaking criteria for evaluating drugs, including health inequities in diverse communities, the number of Oregon residents prescribed the drug, the price of the drug in Oregon, and other criteria. The board has studied the prescription drug distribution and payment system in Oregon and the generic drug market and provided recommendations to the Legislature. The Oregon Legislature acted on the board recommendations by passing Senate Bill 192 in June 2023. The board statutory authority is ORS 646A.693-697.

Generic Drug Report

Click here to view the 2022 inaugural report to legislature

View the 2023 report